ELION THERAPEUTICS
Live / Allowed — Third extension granted (statement of use) (as of 24 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98566166
- Mark type
- Design + words
- Filed
- 23 May 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- J. Dickson Phillips III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infective medications; anti-fungal medications for administration by a healthcare professional in a healthcare setting to treat systemic fungal infections or invasive fungal disease.
Owner
- Elion Therapeutics, Inc., New York, NY, US
- Elion Therapeutics, Inc., New York, NY, US
Prosecution history
- 25 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2026 — SOU EXTENSION 3 GRANTED
- 24 Sept 2026 — SOU EXTENSION 3 FILED
- 24 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2026 — SOU EXTENSION 2 GRANTED
- 24 Mar 2026 — SOU EXTENSION 2 FILED
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2025 — SOU EXTENSION 1 GRANTED
- 24 Sept 2025 — SOU EXTENSION 1 FILED
- 24 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION